Pancreatic Cancer Research

Clinical trialObservationalCompleted

An Analysis of Presentation and Outcome Following Treatment of Pancreatic Endocrine Neoplasms

A Single Centre Analysis of Clinical Characteristics and Treatment of Endocrine Pancreatic Tumours.

Outcome
Results posted; single-arm, no comparison
Phase
Observational
Status
Completed
Study type
Observational
Start
March 2011
Ended
November 2014
Enrollment
40 participants
Sites
0
Primary outcomes
Nonfunctioning and Malignant Pancreatic Endocrine Neoplasms
Sponsor type
Academic / other
Results posted
29 April 2015
Last update
29 April 2015

These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.

Results

Primary endpoint
Results posted; single-arm, no comparisonAs posted on ClinicalTrials.gov ↗, registry record of 29 April 2015
Primary outcome
Nonfunctioning and Malignant Pancreatic Endocrine NeoplasmsNonfunctioning Tumours: Patients Operated for Pancreatic Endocrine Neoplasms: 28, n = 40Functioning Tumours: Patients Operated for Pancreatic Endocrine Neoplasms: 12, n = 40Benign Tumours: Patients Operated for Pancreatic Endocrine Neoplasms: 22, n = 40Malignant Tumours: Patients Operated for Pancreatic Endocrine Neoplasms: 18, n = 40Values: participantsTime frame: Each participant was followed up for a period of 5 yearsNo analysis posted for this outcome (outcome 1)
Participants
Patients Operated for Pancreatic Endocrine Neoplasms: 40 started, 40 completed
Serious adverse events
Pancreatic Endocrine Neoplasms: 6 of 40Participants with at least one serious adverse event, of those at risk, as posted

Every value is copied from the trial’s results record at ClinicalTrials.gov. “Statistically significant” describes the posted test only: it does not say which group did better, and nothing here is read from a paper.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

A single institutional study of Pancreatic Endocrine Neoplasms over 18 years.

Detailed description public domain (ClinicalTrials.gov)

The investigators did an analysis from a prospectively maintained database of patients who underwent pancreatic resections or nonresective procedures for neoplasms of the pancreas at Sir Ganga Ram Hospital from 1995 to 2013 and using pathological reports and preoperative CT scan as the gold standard, the investigators identified 40 patients with PENs.

Posted results (ClinicalTrials.gov registry) · primary outcome public domain (ClinicalTrials.gov)

Nonfunctioning and Malignant Pancreatic Endocrine Neoplasms [Each participant was followed up for a period of 5 years]. Number, participants. Nonfunctioning Tumours: Patients Operated for Pancreatic Endocrine Neoplasms (n=40): 28. Functioning Tumours: Patients Operated for Pancreatic Endocrine Neoplasms (n=40): 12. Benign Tumours: Patients Operated for Pancreatic Endocrine Neoplasms (n=40): 22. Malignant Tumours: Patients Operated for Pancreatic Endocrine Neoplasms (n=40): 18.